Premium
Cancer research in the United States: A critical review of current status and proposal for alternative models
Author(s) -
Kantarjian Hagop M.,
Prat Ferran,
Steensma David P.,
Kurzrock Razelle,
Stewart David J.,
Sekeres Mikkael A.,
Leveque Joseph
Publication year - 2018
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.31522
Subject(s) - medicine , cancer drugs , cancer , process (computing) , risk analysis (engineering) , management science , engineering ethics , computer science , engineering , operating system
This commentary reviews the evolution of the process of cancer research in the United States over the past 6 decades, from an academic‐based to drug industry‐based research, and the advantages and concerns. It proposes a new form of cancer research that involves the tumor‐specific cancer researchers as the primary drivers of the process, and outlines the benefits of such a model in relation to potential improved cost benefits, success rates, and research time lines.